Literature DB >> 30649580

[European guidelines for the management of arterial hypertension 2018-what has changed?]

S Jung1, R E Schmieder2.   

Abstract

BACKGROUND: In November 2017, the latest American guidelines for the management of arterial hypertension were published. With these guidelines lowering the threshold for hypertension to 130/80 mm Hg, the latest European guidelines were expected with excitement.
OBJECTIVES: This article gives an overview on the European Society of Cardiology (ESC) and European Society of Hypertension (ESH) 2018 guidelines for the management of arterial hypertension, thereby identifying the most relevant changes in comparison to previous guidelines. CURRENT DATA: The latest 2018 ESC/ESH guidelines adhere to the previous definition of hypertension, in which a blood pressure of 140/90 mm Hg is considered as threshold for diagnosis. In contrast, there was a change in blood pressure treatment target from below 140/90 to between 120-129/70-79 mm Hg in patients < 65 years if well tolerated. Among patients ≥ 65 years, a systolic blood pressure between 130 and 139 mm Hg is recommended, whereas a diastolic blood pressure between 70 and 79 mm Hg should be targeted. Additionally the guidelines recommend the use of fixed dose combinations as first choice instead of monotherapy to improve adherence. Interventional treatment strategies should only be applied in carefully selected patients at experienced centers and are not recommended outside of clinical studies and registers. Furthermore, the chapters regarding initiation of blood pressure-lowering therapy and clinical evaluation as well as management of hypertension emergencies have been outlined.
CONCLUSIONS: The latest European guidelines for the management of hypertension include several changes. One of the most important aspects is that-in contrast to the American guidelines-the threshold for diagnosis remains at 140/90 mm Hg, whereas treatment target range has been lowered by roughly 10 mm Hg and single pill fixed dose combinations are recommended.

Entities:  

Keywords:  Blood pressure threshold; Guidelines; Hypertension; Renal denervation; Target blood pressure

Mesh:

Substances:

Year:  2019        PMID: 30649580     DOI: 10.1007/s00108-018-0552-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

1.  European Society of Hypertension position paper on renal denervation 2018.

Authors:  Roland E Schmieder; Felix Mahfoud; Michel Azizi; Atul Pathak; Kyriakos Dimitriadis; Abraham A Kroon; Christian Ott; Filippo Scalise; Giuseppe Mancia; Costas Tsioufis
Journal:  J Hypertens       Date:  2018-10       Impact factor: 4.844

2.  2018 ESC/ESH Guidelines for the management of arterial hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 29.983

3.  Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.

Authors:  Mattias Brunström; Bo Carlberg
Journal:  JAMA Intern Med       Date:  2018-01-01       Impact factor: 21.873

4.  No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.

Authors:  Sverre E Kjeldsen; Eivind Berge; Sripal Bangalore; Franz H Messerli; Giuseppe Mancia; Björn Holzhauer; Tsushung A Hua; Dion Zappe; Alberto Zanchetti; Michael A Weber; Stevo Julius
Journal:  Blood Press       Date:  2015-10-29       Impact factor: 2.835

Review 5.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

Review 6.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

7.  Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.

Authors:  Michael Böhm; Helmut Schumacher; Koon K Teo; Eva M Lonn; Felix Mahfoud; Johannes F E Mann; Giuseppe Mancia; Josep Redon; Roland E Schmieder; Karen Sliwa; Michael A Weber; Bryan Williams; Salim Yusuf
Journal:  Lancet       Date:  2017-04-05       Impact factor: 79.321

8.  A polypill strategy to improve adherence: results from the FOCUS project.

Authors:  José M Castellano; Ginés Sanz; José L Peñalvo; Sameer Bansilal; Antonio Fernández-Ortiz; Luz Alvarez; Luis Guzmán; Juan Carlos Linares; Fernando García; Fabiana D'Aniello; Joan Albert Arnáiz; Sara Varea; Felipe Martínez; Alberto Lorenzatti; Iñaki Imaz; Luis M Sánchez-Gómez; Maria Carla Roncaglioni; Marta Baviera; Sidney C Smith; Kathryn Taubert; Stuart Pocock; Carlos Brotons; Michael E Farkouh; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2014-09-01       Impact factor: 24.094

Review 9.  Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis.

Authors:  Johan Sundström; Hisatomi Arima; Rod Jackson; Fiona Turnbull; Kazem Rahimi; John Chalmers; Mark Woodward; Bruce Neal
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

10.  Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.

Authors:  Michael Böhm; Helmut Schumacher; Koon K Teo; Eva Lonn; Felix Mahfoud; Johannes F E Mann; Giuseppe Mancia; Josep Redon; Roland Schmieder; Michael Weber; Karen Sliwa; Bryan Williams; Salim Yusuf
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.